[1]马美娟a,宋荟琴,张国安b,等.糖尿病性心肌病患者血清PDK4，DECR1 和MMP1 表达水平及临床价值研究[J].现代检验医学杂志,2024,39(05):130-134.[doi:10.3969/j.issn.1671-7414.2024.05.024]
　MA Meijuana,SONG Huiqin,ZHANG Guoanb,et al.Diagnostic Value of Combined Detection of Serum PDK4，DECR1 and MMP1 in Diabetes Cardiomyopathy[J].Journal of Modern Laboratory Medicine,2024,39(05):130-134.[doi:10.3969/j.issn.1671-7414.2024.05.024]
点击复制

糖尿病性心肌病患者血清PDK4，DECR1 和MMP1 表达水平及临床价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年05期
页码:
130-134
栏目:
论著
出版日期:
2024-09-15

文章信息/Info

Title:
Diagnostic Value of Combined Detection of Serum PDK4，DECR1 and MMP1 in Diabetes Cardiomyopathy
文章编号:
1671-7414（2024）05-130-05
作者:
马美娟1a; 宋荟琴2; 张国安1b; 黄晓燕1c
（1. 陕西省人民医院a. 西院体检中心；b. 心外科；c. 陕西省感染与免疫疾病重点实验室，西安 710068；2. 铜川矿务局中心医院检验科，陕西铜川 727000）
Author(s):
MA Meijuan1a; SONG Huiqin2; ZHANG Guoan1b; HUANG Xiaoyan1c
（1a. the West Section Physical Examination Center；1b．Department of Cardiology；1c．Shaanxi Provincial Key Laboratory of Infectious and Immunological Diseases, Shaanxi Provincial People’s Hospital , Xi’an 710068, China；2. Department of Clinical Laboratory, C
关键词:
糖尿病性心肌病; 丙酮酸脱氢酶激酶同工酶4; 2; 4- 二烯酰辅酶A 还原酶1; 基质金属蛋白酶 1
分类号:
R587.2；R446.11
DOI:
10.3969/j.issn.1671-7414.2024.05.024
文献标志码:
A
摘要:
目的 探讨血清丙酮酸脱氢酶激酶同工酶4（pyruvate dehydrogenase kinase isoenzyme 4，PDK4），2，4- 二烯酰辅酶A 还原酶1(2，4-dienoyl coenzyme A reductase 1，DECR1) 及基质金属蛋白酶 1(matrix metalloproteinase 1，MMP1) 的联合检测在糖尿病性心肌病（diabetic cardiomyopathy，DCM）诊断、临床分级和病情预后中的应用价值。方法 选取2021 年10 月～ 2023 年10 月陕西省人民医院收治的126 例糖尿病性心肌病(DCM 组) 患者及120例单纯糖尿病非心肌病患者（对照组），采用酶联免疫吸附法（ELISA）测定血清中PDK4，DECR1 及MMP1 蛋白表达水平，评估这三个检测指标在DCM 中的诊断、临床分级和病情预后中的应用价值。结果 DCM 组患者血清PDK4(131.38±10.20 pg/ml），DECR1(152.06±12.57 pg/ml) 及MMP1(40.27±4.02 μg/ml) 蛋白表达水平与对照组(82.69±8.17 pg/ml, 86.14±9.55 pg/ml, 17.77±0.98 μg/ml) 相比均明显升高，差异具有统计学意义（t=36.24，47.63，12.29，均P<0.001）。DCM 组患者血清PDK4，DECR1 及MMP1 蛋白表达水平与NYHA 心功能分级相关，随等级升高其蛋白表达水平均明显升高，差异具有统计学意义（F=24.12，30.04，12.66，均P<0.01）；DCM 级病情中重度组患者与轻度组患者比较， 血清PDK4（164.92±1.35pg/ml vs 122.48±8.78pg/ml），DECR1（192.17±9.11pg/ml vs124.36±10.83pg/ml）及MMP1（84.44±7.38μg/ml vs 39.41±3.05μg/ml）蛋白表达水平均显著增高，差异具有统计学意义（t=26.33，47.12，15.41，均P<0.001）。血清PDK4，DECR1 及MMP1 三项联合检测DCM 准确度（χ2=18.23，21.37，22.07）、特异度（χ2=9.72，13.43，15.12）、灵敏度（χ2=12.07，16.07，17.55）与单项检测对比均明显升高，差异具有统计学意义（均P<0.05），且ROC 曲线分析结果显示联合检测的AUC 高达0.955，明显高于单项检测（Z=16.67，17.09，20.44，均P<0.05）。结论 血清PDK4，DECR1 及MMP1 与DCM 诊断、临床分级及病情预后有一定关联，三者联合检测有助于DCM 的鉴别诊断。
Abstract:
Objective To explore the value of combined detection of serum pyruvate dehydrogenase kinase isoenzyme 4 (PDK4)， 2,4-dienoyl coenzyme A reductase 1 (DECR1) and matrix metalloproteinase 1 (MMP1) in the diagnosis, clinical grading and prognosis of diabetes cardiomyopathy（DCM）.Methods A sum of 26 patients with diabetes cardiomyopathy (DCM group) and 120 patients with diabetes non cardiomyopathy (control group) who were admitted to Shaanxi Provincial People’s Hospital from October 2021 to October 2023 were selected. The expression levels of PDK4, DECR1 and MMP1 proteins in serum were measured by enzyme-linked immunosorbent assay (ELISA) to evaluate the diagnostic value of these three detection indicators in DCM. Results Compared with the Control group, the levels of serum PDK4(131.38±10.20 pg/ml vs 82.69±8.17 pg/ml），DECR1(152.06±12.57 pg/ml vs 86.14±9.55 pg/ml) and MMP1(40.27±4.02 μg/ml vs 17.77±0.98 μg/ml) protein in the diabetes cardiomyopathy (DCM) group were significantly higher， and the differences were statistically significant(t=36.24，47.63，12.29，all P <0.001)．In the DCM group, the protein expression levels of serum PDK4, DECR1 and MMP1 were correlated with NYHA cardiac function grading, while the protein expression levels were significantly increased with the grade increasing, and the differences between the groups were statistically significant (F=24.12, 30.04, 12.66，all P <0.001)．In the DCM group, compared with the mild group，the expression levels of serum PDK4（164.92±1.35pg/ml vs 122.48±8.78pg/ml），DECR1（192.17±9.11pg/ml vs 124.36±10.83pg/ml） and MMP1 （84.44±7.38μg/ml vs 39.41±3.05μg/ml） proteins were significantly increased in patients with moderate to severe illness, and the differences were statistically significant (t=26.33，47.12，15.41，all P<0.001)．The accuracy (χ2=18.23，21.37，22.07)，specificity (χ2=9.72，13.43，15.12) and sensitivity (χ2=12.07，16.07，17.55) of serum PDK4, DECR1 and MMP1 were significantly higher than those of single Test (all P <0.05) , the results of ROC curve analysis showed that the AUC of combined detection was 0.955，which was significantly higher than that of single detection (Z=16.67，17.09，20.44，all P <0.05)．Conclusion Serum PDK4, DECR1 and MMP1 are related to the diagnosis, clinical grading and prognosis of diabetes cardiomyopathy. The combined detection of the three is helpful to the differential diagnosis of diabetes cardiomyopathy.

参考文献/References:

[1] ZHAN Jiabing, JIN Kunying, XIE Rong, et al. AGO2 protects against diabetic cardiomyopathy by activating mitochondrial gene translation[J]. Circulation, 2024, 149(14): 1102-1120.
[2] SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition [J]. Diabetes Research and Clinical Practice, 2019, 157：107843.
[3] GALICIA-GARCIA U, BENITO-VICENTE A, JEBARI S, et al. Pathophysiology of type 2 diabetes mellitus[J]. International Journal of Molecular Sciences, 2020, 21(17): 6275.
[4] PALUSZKIEWICZ J, KRASINSKA B, MILTING H, et al. Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment [J]. Kardiochirurgia i Torakochirurgia Polska, 2018, 15 (4)：246-253.
[5] WOOLBRIGHT B L, RAJENDRAN G, ABBOTT E, et al. Pyruvate dehydrogenase kinase 4 deficiency increases tumorigenesis in a murine model of bladder cancer[J]. Cancers, 2023, 15(6): 1654.
[6] CUTHBERTSON I, MORRELL N W, CARUSO P. BMPR2 mutation and metabolic reprogramming in pulmonary arterial hypertension[J]. Circulation Research, 2023, 132(1): 109-126.
[7] KAWAI T, AUTIERI M V, SCALIA R. Adipose tissue inflammation and metabolic dysfunction in obesity[J]. American Journal of Physiology-Cell Physiology, 2021, 320(3): C375-C391.
[8] MOON S S, LEE J E, LEE Y S, et al. Association of pyruvate dehydrogenase kinase 4 gene polymorphisms with type 2 diabetes and metabolic syndrome[J].Diabetes Research and Clinical Practice, 2012, 95(2): 230-236.
[9] BLOMME A, FORD C A, MUI E, et al. 2,4-dienoyl- CoA reductase regulates lipid homeostasis in treatmentresistant prostate cancer[J]. Nature Communications, 2020, 11(1): 2508.
[10] PENG Cheng, ZHANG Yanxiu, LANG Xueyan, et al. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis[J]. Journal of Translational Medicine, 2023, 21(1): 66.
[11] QUAN Taihao, XIA Wei, HE Tianyuan, et al. Matrix metalloproteinase-1 expression in fibroblasts accelerates dermal aging and promotes papilloma development in mouse skin[J]. Journal of Investigative Dermatology, 2023, 143(9): 1700-1707, e1.
[12] PARATZ E D, STUB D, SUTHERLAND N, et al. The challenge of risk stratification in hypertrophic cardiomyopathy: clinical, genetic and imaging insights from a quaternary referral centre [J]. International Journal of Cardiology, 2024, 395: 131416.
[13] EZAD S M, MCENTEGART M, DODD M, et al. Impact of anatomical and viability-guided completeness of revascularization on clinical outcomes in ischemic cardiomyopathy[J]. Journal of the American College of Cardiology, 2024, 84(4): 340-350.
[14] ELLIOTT P M, ANASTASAKIS A, BORGER M A, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)[J]. European Heart Journal, 2014, 35(39): 2733-2779.
[15] LORENZO-ALMOR?S A, CEPEDA-RODRIGO J M, LORENZO ?. Diabetic cardiomyopathy[J]. Revista Clinica Espanola, 2022, 222(2): 100-111.
[16] HUANG Keming, LUO Xianling, LIAO Bin, et al. Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms[J]. Cardiovascular Diabetology, 2023, 22(1): 86.
[17] THOUDAM T, HA C M, LEEM J, et al. PDK4 augments ER-mitochondria contact to dampen skeletal muscle insulin signaling during obesity[J]. Diabetes, 2019, 68(3): 571-586.
[18] TAN Wenliang, BAO Huogeng, LIU Ziming, et al. Protein PDK4 interacts with HMGCS2 to facilitate high glucoseinduced myocardial injuries[J]. Current Molecular Medicine, 2023, 23(10): 1104-1115.
[19] FATMI M K, REN Di, FEDOROVA J, et al. Cardiomyocyte PDK4 response is associated with metabolic maladaptation in aging[J]. Aging Cell, 2023, 22(4): e13800.
[20] PETTERSEN I K N, TUSUBIRA D, ASHRAFI H, et al. Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation [J]. Mitochondrion, 2019, 49：97-110.
[21] ZHOU Huijuan, ZHANG Jie, YAN Zhongkang, et al. DECR1 directly activates HSL to promote lipolysis in cervical cancer cells[J]. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2022, 1867(3): 159090.
[22] GOVANDE A A, BABNIS A W, URBAN C, et al. RNase L-activating 2’-5’ oligoadenylates bind ABCF1, ABCF3 and DECR-1[J]. Journal of General Virology, 2023, 104(9): 1-14.
[23] GUO Suiqun, JIANG Huiping, DENG Yuanrun, et al. Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer[J]. Journal of Obstetrics and Gynaecology Research, 2023, 49(10): 2475-2486.
[24] COKIC I, CHAN S F, GUAN Xingmin, et al. Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium[J]. Nature Communications, 2022, 13(1): 6394.
[25] AMILLS M, VIDAL O, VARONA L , e t a l . Polymorphism of the pig 2,4-dienoyl CoA reductase 1 gene(DECR1)and its association with carcass and meat quality traits[J]. Journal of Animal Science, 2005, 83(3): 493-498.
[26] MIXON A, BAHAR-MONI A S, FAISAL T R. Mechanical characterization of articular cartilage degraded combinedly with MMP-1 and MMP-9 [J]. Journal of the Mechanical Behavior of Biomedical Materials, 2022, 129: 105131.
[27] NAIR N, GONGORA E. Correlations of GDF-15 with sST2, MMPs, and worsening functional capacity in idiopathic dilated cardiomyopathy: can we gain new insights into the pathophysiology? [J]. Journal of Circulating Biomarkers, 2018, 7: 1849454417751735.
[30] 郭继勃, 钟曌, 郭昊, 等. 急性缺血性脑卒中患者血浆LIPCAR 和MMP-9 水平与病情严重程度及溶栓治疗后认知功能的关系研究[J]．现代检验医学杂志,2023, 38(5): 40-46. GUO Jibo, ZHONG Zhao, GUO Hao, et al. Study on the relationship between peripheral blood LIPCAR,MMP-9 and severity of acute ischemic stroke and cognitive function after RT-PA intravenous thrombolysis[J]. Journal of Modern Laboratory Medicine, 2023, 38(5): 40-46.
[31] 丁锦, 贯芳, 梁小涵, 等. 急性冠脉综合征患者血浆外泌体NEAT1, miR-204 和MMP-9 的表达水平及临床意义[J]. 现代检验医学杂志, 2023, 38(1): 59-65. DING Jin, GUAN Fang, LIANG Xiaohan, et al. Expression levels and clinical significance of plasma exosomal NEAT1, miR-204 and MMP-9 in patients with acute coronary syndrome[J]. Journal of Modern Laboratory Medicine, 2023, 38(1): 59-65.

备注/Memo

备注/Memo:
基金项目： 陕西省人民医院科技人才支持计划项目（No: 2023JY-06）；陕西中医药大学陕西省中西医结合心血管病防治重点实验室开放课题（No: 2022XXG-QN-001）。
作者简介：马美娟（1987-），女，硕士，主治医师，研究方向：心血管疾病的诊疗，E-mail：dymameijuan@163.com。
通讯作者：黄晓燕（1983-），女，硕士，副主任技师，研究方向：免疫与心血管疾病诊疗，E-mail: huangxy08@163.com。
更新日期/Last Update: 2024-09-15